Ignite Creation Date:
2024-05-05 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00663936
Status:
COMPLETED
Last Update Posted:
2013-11-05
First Post:
2008-04-18
Brief Title:
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimers Disease
Sponsor:
FUJIFILM Toyama Chemical Co Ltd
Organization:
FUJIFILM Toyama Chemical Co Ltd
Study Overview
Official Title:
A Phase 2a Multi-center Randomized Double Blind Placebo-controlled Study to Investigate the Efficacy and Safety of T-817MAa in Patients With Mild to Moderate Alzheimers Disease
Status:
COMPLETED
Status Verified Date:
2012-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective of the study is to evaluate the efficacy of T-817MA in AD patients to treat dementia Efficacy will be cognitive function as measured by the ADAS-cog cognitive assessment
The secondary objectives of the study are to evaluate the safety of T-817MA and the activities of daily living assessed with the ADCS-ADL of AD patients taking T-817MA and to evaluate the efficacy of T-817MA in AD patients with an overall global assessment using the ADCS-CGIC
The secondary objectives of the study are to evaluate the safety of T-817MA and the activities of daily living assessed with the ADCS-ADL of AD patients taking T-817MA and to evaluate the efficacy of T-817MA in AD patients with an overall global assessment using the ADCS-CGIC
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None